therapeutics News and Research

RSS

Scientists discover hotspots in the 'dark genome' associated with schizophrenia and bipolar disorder

Scientists investigating the DNA outside our genes - the 'dark genome' - have discovered recently evolved regions that code for proteins associated with schizophrenia and bipolar disorder.

24 Dec 2021

Blocking function of blood-clotting protein prevents bone loss from gum disease in mice

Blocking function of a blood-clotting protein prevented bone loss from periodontal (gum) disease in mice, according to research led by scientists at the National Institute of Dental and Craniofacial Research (NIDCR), part of the National Institutes of Health.

24 Dec 2021

INTEGRA supports groundbreaking brain tumor research

INTEGRA Biosciences is proud to be supporting vital translational research into diffuse intrinsic ponsglioma (DIPG) – a rare childhood brain tumor – at the Ludwig Maximilian University of Munich (LMU) with a festive donation of 20,000 EUR.

From INTEGRA Biosciences 21 Dec 2021

New method combines AI and microfluidics to easily barcode individual cells

An innovative new method for more efficient and accurate barcoding of individual cells could help realize faster diagnosis of diseases.

From University of Exeter 21 Dec 2021

Antibody-like proteins from sharks can neutralize SARS-CoV-2 variants

Small, unique antibody-like proteins known as VNARs -; derived from the immune systems of sharks -; can prevent the virus that causes COVID-19, its variants, and related coronaviruses from infecting human cells, according to a new study published Dec. 16.

17 Dec 2021

Multiple changes in brain cells during embryonic development may contribute to schizophrenia

Multiple changes in brain cells during the first month of embryonic development may contribute to schizophrenia later in life, according to a new study by Weill Cornell Medicine investigators.

17 Dec 2021

Study unravels novel gene vital for establishing proper left-right asymmetry

A group of scientists headed by the Agency for Science, Technology and Research’s (A*STAR) recently identified a new gene.

17 Dec 2021

Detecting high-impact rare genetic variants in individuals with severe schizophrenia

New research published in the Proceedings of the National Academy of Sciences shows that examining genetic mutations in individuals with severe schizophrenia can improve the ability to detect disease-associated rare genetic variants.

15 Dec 2021

CellPort Software joins the Tetra Partner Network to help customers accelerate cell development and manufacturing

TetraScience, the R&D Data Cloud company, announced today that CellPort Software, a SaaS company that digitizes workflows for cell development and manufacturing, has joined the Tetra Partner Network to accelerate delivery of cell-based therapeutics.

From TetraScience, Inc. 15 Dec 2021

Gene writing helps develop advanced therapies safely and effectively

An international, multidisciplinary team of researchers from the Translational Synthetic Biology Laboratory at Pompeu Fabra University (Barcelona, Spain), led by Dr. Marc Güell, has published an article in the scientific journal Nature Communications.

14 Dec 2021

Study provides new insight into the genetics of severe schizophrenia

Columbia University researchers have determined that individuals who suffer from the most severe form of schizophrenia have a significantly higher number of rare mutations than more typical forms of the illness.

14 Dec 2021

Cocktails of llama nanobodies effective against COVID-19 variants, says study

According to recent research, cocktails of small llama antibodies against SARS-CoV-2—the causative agent of COVID-19—can help fight novel variants of the virus.

13 Dec 2021

Powering the Biotechnology Revolution through Cloud R&D

In this interview, we speak to Sajith Wickramasekara, CEO and Co-Founder of Benchling, about cloud R&D and how it is powering the biotechnology revolution.

From Benchling 10 Dec 2021

Study of people from diverse ancestries provides a powerful tool for predicting heart disease risk

In a large-scale study of people from diverse ancestries, researchers narrowed down the number of genomic variants that are strongly associated with blood lipid levels and generated a polygenic risk score to predict elevated low-density lipoprotein cholesterol levels, a major risk factor for heart disease.

From National Human Genome Research Institute (NHGRI) 9 Dec 2021

First molecular structure of TDP-43 could pave the way for new ALS therapies

Scientists have determined for the first time the structure of the molecule associated with amyotrophic lateral sclerosis (ALS) and multiple other neurodegenerative diseases.

9 Dec 2021

Immune cells utilize the body’s fat stores to combat infection, says study

A recent study carried out by the University of East Anglia and Quadram Institute shows how immune cells utilize the body’s fat stores to combat infection.

9 Dec 2021

World's first metal-organic framework antibody-drug delivery system developed

It sounds like the stuff of science fiction: a man-made crystal that can be attached to antibodies and then supercharge them with potent drugs or imaging agents that can seek out diseased cells with the highest precision, resulting in fewer adverse effects for the patient.

8 Dec 2021

Metabolites from human microbiome can inhibit COVID-19 infection, says study

Scientists recently discovered metabolites in the human microbiome that hinders COVID-19 infection in cell-based models of the virus.

7 Dec 2021

Next-generation sequencing for minimal residual disease proven more sensitive than flow cytometry

In pediatric and young adult patients with acute lymphoblastic leukemia (ALL) treated with tisagenlecleucel (Kymriah), DNA sequencing-based detection of residual disease between three and 12 months accurately identified all patients who would eventually relapse, while other methods were less predictive.

2 Dec 2021

Nanoparticles mimicking flu viruses to deliver large biological drug molecules

Nanoengineers from the University of California San Diego recently created a new and potentially efficient means to deliver messenger RNA (mRNA) into cells.

2 Dec 2021

therapeutics News and Research

Scientists discover hotspots in the 'dark genome' associated with schizophrenia and bipolar disorder

Blocking function of blood-clotting protein prevents bone loss from gum disease in mice

INTEGRA supports groundbreaking brain tumor research

New method combines AI and microfluidics to easily barcode individual cells

Antibody-like proteins from sharks can neutralize SARS-CoV-2 variants

Multiple changes in brain cells during embryonic development may contribute to schizophrenia

Study unravels novel gene vital for establishing proper left-right asymmetry

Detecting high-impact rare genetic variants in individuals with severe schizophrenia

CellPort Software joins the Tetra Partner Network to help customers accelerate cell development and manufacturing

Gene writing helps develop advanced therapies safely and effectively

Study provides new insight into the genetics of severe schizophrenia

Cocktails of llama nanobodies effective against COVID-19 variants, says study

Powering the Biotechnology Revolution through Cloud R&D

Study of people from diverse ancestries provides a powerful tool for predicting heart disease risk

First molecular structure of TDP-43 could pave the way for new ALS therapies

Immune cells utilize the body’s fat stores to combat infection, says study

World's first metal-organic framework antibody-drug delivery system developed

Metabolites from human microbiome can inhibit COVID-19 infection, says study

Next-generation sequencing for minimal residual disease proven more sensitive than flow cytometry

Nanoparticles mimicking flu viruses to deliver large biological drug molecules

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Latest in Genomics